Blueprint to Close the Women%E2%80%99s Health Gap 2025
Page 36 of 62 · WEF_Blueprint_to_Close_the_Women%E2%80%99s_Health_Gap_2025.pdf
Introduction
This report and the accompanying Women’s Health
Impact Tracking (WHIT) Platform provide data-
driven insights that track progress to close the
women’s health gap, in terms of gaps across care
delivery, treatment efficacy and data availability.
In the 2024 report, Closing the Women’s Health
Gap: A $1 Trillion Opportunity to Improve Lives and
Economies, 64 conditions were identified that affect
women uniquely, differently or disproportionately
to men and account for almost 86% of the global
disease burden among women. To effectively
address the gaps in care delivery, treatment
efficacy, data availability and investment across these conditions, a phased approach was adopted.
In the first year, nine conditions were selected using
a framework that assessed their potential impact on
women’s lives and their broader economic impact,
among other criteria. Process and outcome data
for each condition was collected at a global level,
and when data was unavailable, country-level data
was tracked in 15 selected countries and impact-
tracking metrics were subsequently defined.
This appendix provides the detailed methodologies,
frameworks and data sources underpinning these
efforts, ensuring transparency and enabling future
application of the insights presented.
Selection of high-
impact conditions
selected for year 1,
countries and metrics1
A selection framework identified nine women’s
health conditions that, collectively, account for one-
third of the overall women’s health gap and are the
focus of the first edition of the WHIT platform. The
following criteria guided the selection:
–Global burden of disease measured in disability-
adjusted life years (DALYs)
–Economic impact measured in terms of potential
change in GDP (estimated by the supply-side
benefits from having a larger, healthier and
more productive female labour force, which
were used to project the annual potential GDP
contribution to 2040)191
–Prevalence rate measured in rate per 100,000
population
–Incidence rate measured in rate per 100,000
population –Burden and GDP impact in lower-middle-
income countries (LMICs) and low-income
countries (LICs)
–Global Alliance for Women’s Health members’
expert recommendations
Each criterion was given a different weighting
depending on the potential to build a compelling
investment case for addressing women’s health
disparities: global burden, GDP impact, Alliance
members’ expert recommendations all scored a 1
on relative relevance; prevalence rate and incidence
rate scored a 2; and then LMIC and LIC burden
and GDP impact scored a 3. For each criterion,
conditions were ranked from lowest to highest
across the 64 conditions, and each rank was
multiplied by the allocated weight for the criteria.
These seven criteria formed a composite score
to rank the conditions as follows. Please refer to
Figure 1 in the report for details.1.1 Selected conditions
Blueprint to Close the Women’s Health Gap: How to Improve Lives and Economies for All
36
Ask AI what this page says about a topic: